R-E-S-P-E-C-T is new to the top five list this year according to Kropp.

FORBES: The Top Five Reasons Employees Will Quit In 2013

Merck announced today that the HPS2-THRIVE ( H eart P rotection S tudy 2- T reatment of H DL to R educe the I ncidence of V ascular E vents) study did not meet its primary endpoint.

FORBES: HPS2-THRIVE: No Benefit, Signal Of Harm For Niacin Therapy

And I would say one thing to Congressman Issa, Plaquemines is spelled P-l-a-q-u-e-m-i-n-e-s.

WHITEHOUSE: Press Briefing